Although 40% of patients who bleed from ruptured intracranial aneurysm die from the effect of the first haemorrhage, in the remainder the bleeding ceases spontaneously.' In these patients clot surrounds the aneurysm and a plug of platelets and fibrin seals the site of bleeding. 2 The blood in the subarachnoid space stimulates fibrinolytic activity in the cerebrospinal fluid (CSF)3 and dissolution of clot can lead to recurrent bleeding from which one third of survivors of the first haemorrhage die in the next six weeks.4 5 Intracranial surgery prevents recurrent haemorrhage by sealing the aneurysm or excluding it from the circulation, but otherwise does not assist in recovery unless a large intracerebral haematoma can be removed. 6 The operative mortality of such surgery depends on the neurological state of the patient,7 8 and the time which has elapsed since the last haemorrhage.9 10 Early operation, especially in patients in poor condition, results in higher mortality and morbidity10 11 (table 1) as are the sex distribution, incidence of arterial hypertension and incidence of multiple aneurysms. Hypertension has been considered to be present when the diastolic pressure has been found to be consistently raised above 100 mm mercury or where patients have been known to be hypertensive before the onset of SAH. Table I shows the grades of the patients at the time of admission, and the intervals between SAH and admission to the department. The grading system of Nishioka5 has been used to allow the prediction tables of Alvord32 to be used in predicting the outcome, and the time intervals chosen have been those used by Alvord.32 The two groups are well matched for age, sex, hypertension and multiple aneurysms, but there are differences in the grading, and in the time of admission, since patients in the earlier control group tended to be referred later and in better grade. To assess the effect of these differences the Alvord32 prediction tables have been used to determine a notional risk of death in each patient. The period of risk of rebleeding has been taken to be the time in days between admission to the department and the date of the operation, or in unoperated patients the date of discharge from hospital. In fatal cases the period of risk was the time between admission and death, whether due to re-bleeding, cerebral ischaemia or other cause. In each patient the probability of survival in the grade of admission has been taken from the tables32 at the beginning and end of the period of risk, and these two figures subtracted to give a notional figure for risk of fatality during the period. The addition of these figures from each patient gives a notional figure for predicted deaths in each group and this is shown in table 1, together with the mean period of risk.
Operation was performed intracranially in 76 patients and by carotid ligation in five patients in the treated group and in 79 and two respectively in the control group. The reasons for non-operation are given in table 1 . Clinical details of most of the patients in this study have been described elsewhere. 33 Epsilon aminocaproic acid (EACA) was given by mouth or nasogastric tube in a dose of 3 grams 3-hourly to all the patients in the treated group from the time of admission until operation, or until discharge or death in nonoperated patients. This dose has been shown to be sufficient to produce an effective therapeutic blood level for antifibrinolysis within two hours,34 and has been stated to be effective in preventing recurrent SAH.9 12 Thrombo-embolic complications were seen in both groups. In the treated group 12 patients developed a deep vein thrombosis (DVT) and four of these resulted in pulmonary embolism with one death. In the control group there were seven DVTs, with five pulmonary emboli and one death. In addition to the three postoperative deaths due to cerebral ischaemia there was another due to pulmonary embolism and one due to technical difficulties in the operation, an operative mortality of 30% in 162 patients. Three postoperative deaths occurred in the control group and two in the treated group.
Approximately 100% of patients taking EACA had some nausea with occasional vomiting and diarrheea, but most managed to continue taking the tablets.
Discussion
One of the problems in the surgical treatment of ruptured intracranial aneurysms is that the earlier intracranial operation is performed the worse the results in terms of operative mortality and morbidity,10 11 and yet the longer surgery is delayed the greater the risk of recurrent bleeding.4 32 28 30 31 but in three of these the numbers are small.27 28 31 The other series 30 is the largest with 135 patients compared with 166 controls, but very little data are given in the publication.
Cerebral ischaemia, although a well-known complication of SAH,33 is mentioned as a problem in only two series. Schisano23 describes cerebral ischaemia in 10 patients with nine deaths out of 58 patients treated with antifibrinolytic drugs (17-2%) and Maurice-Williams25 had eight patients with cerebral ischaemia out of 25 in the treated group (32 %), as against two out of 25 in the controls (8 % 
